HPS Pharmacies wish to give notice that Arrow Pharmaceuticals are experiencing an interruption to the supply of Artane® as follows:
Trihexyphenidyl (benzhexol) hydrochloride 2mg
Trihexyphenidyl (benzhexol) hydrochloride 5mg
Normal supplies of Artane® 2mg tablets are expected to return in early August 2020, and supplies of Artane® 5mg tablets are expected to return in early June 2020.
An internationally registered brand of trihexyphenidyl (benzhexol) hydrochloride 2mg tablets has been approved for supply under Section 19A of the Therapeutic Goods Act 1989. The following table highlights the key differences between Artane® and the Section 19A product.
|Artane® 2mg||Section 19A product|
|Expression of active ingredient||Trihexyphenidyl (benzhexol) hydrochloride||Trihexyphenidyl hydrochloride|
|Pack size||200 tablets||100 tablets|
|Excipients||Calcium hydrogen phosphate, starch-maize, starchpregelatinised maize and magnesium stearate||Magnesium stearate, microcrystalline cellulose and sodium starch glycolate.|
Please note that Section 19A alternatives are subject to a longer lead-time and different pricing as they must be sourced internationally.
Retain this notice in a prominent position, including in other related business units until supplies return to normal. Report any problems identified with medicines, vaccines or medical devices to the TGA.
Should you require further information regarding this matter, please contact your pharmacist at HPS Pharmacies, or Arrow Pharmaceuticals on 1300 927 769.
Subscribe Knowledge Centre Updates
Enter your details to receive Knowledge Centre updates